CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, citing the example of annual flu-shot revisions.
from WebMD Health https://ift.tt/XQ8qOg6
CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, citing the example of annual flu-shot revisions.
0 comments:
Post a Comment